Articles by Ahn Sung-mi
Ahn Sung-mi
sahn@heraldcorp.com-
Volkswagen has no plans to exit Korean market
[THE INVESTOR] Volkswagen Korea said it does not intend to abandon the Korean market amid growing speculation that the automaker could be forced out over the emission scandal. “I apologize for causing trouble for our partner dealers and customers,” Tomas Kuel, CEO of VW Korea said in a letter sent out to the dealers on July 14. “Although we are in a difficult situation, we will keep a strong foothold in the Korean market and pursue future plans.”He stressed that the Korean market is very importa
Mobility July 15, 2016
-
Volkswagen price slumps amid widening scandal
[THE INVESTOR] Car dealers are pushing to sell Volkswagen vehicles at reduced prices as the carmaker is likely to be banned from selling in South Korea for the cheating emission scandal. Online VW dealers have significantly reduced the price of its best-selling models such as SUV Tiguan. The price of Tiguan has decreased by 7 million won from 45 million won (US$ 39,432) to 38 million won in July. Sellers are offering more than 10 million won reduction, or 15 percent discount from the original pr
July 15, 2016
-
Prosecutors seek to question VW execs in Germany
[THE INVESTOR] Prosecutors have requested the former chief of Audi Korea Trevor Hill and executives of Volkswagen headquarters in Germany to be present for questioning on their involvement in the widening probe into the German carmaker’s cheating emission scandal. Seoul Central District Prosecutors’ Office on July 14 said it has sent a request to the seven executives, including Hill, through the lawyer of Audi Volkswagen Korea on July 11. Trevor Hill, former chief of Audi Korea / The Investor“We
Mobility July 14, 2016
-
Celltrion’s Remsima bolsters presence in Europe
[THE INVESTOR] South Korean biopharmaceutical company Celltrion has increased its market presence in Europe with biosimilar Remsima, the company said on July 14. Celltrion’s Remsima -- biosimilar replication of the world’s third best-selling rheumatoid arthritis treatment drug Remicade, or Infliximab -- has captured a 30 percent share of the overall Infliximab market in Europe, according to IMS Health, a market data provider. Celltrion's biosimilar RemsimaThe latecomer Remsima began selling in E
Industry July 14, 2016
-
VW Korea likely to face W320b penalty for emissions rigging
[THE INVESTOR] Audi Volkswagen Korea is likely to be slapped with a heavy penalty of up to 320 billion won (US$279.51 million) for submitting false documents with intentions to cheat on the government’s emissions tests. The Ministry of Environment will hold a hearing for its final decision on the punitive measure on July 22. Of the 32 Audi and Volkswagen models subject to the penalty, 27 models are currently on sale. Following the decision, the Korean unit could face sales ban on its top-selling
Industry July 14, 2016
-
KPG Partners, Corstone Asia mull takeover of JKC Corp.
[THE INVESTOR] Local investment firm KPG Partners and private equity fund Corstone Asia are planning on acquiring JKC Corp., a Korean manufacturer of adhesive film and other industrial materials. According to industry sources, KPG Partners and Corstone Asia signed a memorandum of understanding for the right to exclusively negotiate with JKC Corp. to purchase the company. After conducting a due diligence and further negotiations, the takeover deal will be completed by next month. Lee Jang-won, th
Industry July 14, 2016
-
Hanjin Shipping sells Vietnamese terminal to secure liquidity
[THE INVESTOR] Hanjin Shipping has sold its entire stake in Tan Cang Cai Mep International Terminal in Vietnam to its affiliate in order to secure liquidity, the ailing shipper announced July 13. The firm, which had a 21 percent stake in the terminal, sold the entire rights priced at 23 billion won (US$ 20 million) to Hanjin Transport, which runs the land transport service under Hanjin Group, during the board meeting on July 12. The move came after the government and creditors, led by state-run
Industry July 13, 2016
-
Prosecutors to summon Volkswagen chief
[THE INVESTOR] South Korean prosecutors will soon summon Johannes Thammer, the CEO of Audi Volkswagen Korea, to question him over his involvement in the widening probe into the German carmaker’s cheating emission scandal. Seoul’s Central District Prosecutor’s Office on July 13 said Tamer is suspected of colluding with a VW executive, identified only by his surname Yoon, to manipulate software of the gasoline model Golf 1.4 TSI to meet the emission and noise level standards. Audi Volkswagen Korea
Mobility July 13, 2016
-
S. Korea orders recall of Mercedes-Benz’s trucks
[THE INVESTOR] South Korea’s Ministry of Land, Infrastructure and Transport on July 13 ordered the of recall Mercedes-Benz’s heavy-duty trucks Arocs and Actros after detecting a problem in the exhaust pipe system. Daimler Trucks Korea, which sells Mercedes-Benz trucks here, will recall 157 units of Arocs manufactured from Aug. 26, 2014, to April 4, 2016, and 443 units of Actros, from July 30, 2014, to April 8, 2016. A component in the exhaust pipe was discovered to be faulty, which can potential
Mobility July 13, 2016
-
Yamaha recalls 900 motorcycles in Korea
[THE INVESTOR] Japanese motorcycle manufacturer Yamaha is carrying out a recall for over 900 motorcycles in Korea to rectify a clutch malfunction. The recalled motorcycles are 761 units of YZF-R3 RH07 manufactured Dec. 6, 2015, to April 4, 2016, and 161 units of MT-03 RH07, from March 16 to April 4 in 2016. The motorcycles have been identified as being affected by the defect in clutch pressure plate, causing the engine to stall. Bike owners can get their motorcycles fixed at the Hankook Motor Tr
Mobility July 13, 2016
-
S. Korea orders recall of Ford Mustang over air bags
[THE INVESTOR] South Korea’s Ministry of Land, Infrastructure and Transport said July 13 that it has ordered a recall of Ford’s sports car Mustang as part of an expanded recall to replace faulty air bags made by Japanese supplier Takata.The authorities will recall a total of 948 vehicles manufactured from April 6, 2004, to January 10, 2012. MustangThe recall is part of a global expansion of an ongoing Takata air bag recall, which could see as many as 100 million vehicles recalled globally, by m
Mobility July 13, 2016
-
Peugeot to recall subcompact convertible 207 in Korea
[THE INVESTOR] French automaker Peugeot is carrying out a recall on its subcompact convertible 207, according to the Ministry of Land, Infrastructure and Transport on July 13. Hanbul Motors, the importer of Peugeot, has been ordered to recall a total of 591 units after discovering that the failed heating system in the seats can potentially cause fire. Peugeot 207The automaker will recall 587 units of Peugeot 207CC manufactured from Feb. 12, 2007, to Oct. 23, 2008, and 4 units of Peugeot 207, fro
Mobility July 13, 2016
-
Chinese non-tariff barriers raise concerns
[THE INVESTOR] The South Korean economy could be hit hard if China increases non-tariff barriers that restrict the sale of Korean-made goods, as the country is heavily dependent on China for exports, industry data showed on July 12. According to a report released by Hyundai Research Institute, the amount of Korea’s export to China affected by the two most common non-tariff barriers -- technical barriers to trade and sanitary and phytosanitary measures -- has sharply increased since 2008. The num
July 12, 2016
-
Volkswagen Korea receives sales ban notice
[THE INVESTOR] Volkswagen Korea has received an official order from the Ministry of Environment to stop sales and cancel the registration of its vehicles that cheated on emission tests, the company said on July 12. “We received the notice,” Lee Soo-jin, a spokesperson of Audi Volkswagen Korea told The Investor. “But in order (for the ministry) to go ahead with revoking the registration, there will be a hearing session for us to explain. We will come up with an action plan after the hearing.”The
Mobility July 12, 2016
-
Kolon Life Science seeks approval for degenerative arthritis drug
[THE INVESTOR] Kolon Life Science has filed for government approval for a drug it developed to treat degenerative arthritis, the company said on July 11. After 17 years of research, the pharmaceutical company introduced Invossa, Korea’s first gene therapy for degenerative arthritis. The new drug injects healthy human cartilage cells into the space between the bones to alleviate pain and treat the major symptoms. It can also be an alternative for surgical treatment, according to Kolon Life Scienc
Industry July 12, 2016
Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
South Korean military plans to launch new division for future warfare
-
7
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen